These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34944456)

  • 1. The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression.
    Maffei M; Montemiglio LC; Vitagliano G; Fedele L; Sellathurai S; Bucci F; Compagnone M; Chiarini V; Exertier C; Muzi A; Roscilli G; Vallone B; Marra E
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.
    Prahlad J; Struble LR; Lutz WE; Wallin SA; Khurana S; Schnaubelt A; Broadhurst MJ; Bayles KW; Borgstahl GEO
    Protein Sci; 2021 Sep; 30(9):1983-1990. PubMed ID: 34191362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies.
    Rattanapisit K; Bulaon CJI; Khorattanakulchai N; Shanmugaraj B; Wangkanont K; Phoolcharoen W
    PLoS One; 2021; 16(8):e0253574. PubMed ID: 34379620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
    Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
    J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain.
    Antonopoulos A; Broome S; Sharov V; Ziegenfuss C; Easton RL; Panico M; Dell A; Morris HR; Haslam SM
    Glycobiology; 2021 Apr; 31(3):181-187. PubMed ID: 32886791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells.
    Argentinian AntiCovid Consortium
    Sci Rep; 2020 Dec; 10(1):21779. PubMed ID: 33311634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein.
    Salem R; El-Kholy AA; Waly FR; Ayman D; Sakr A; Hussein M
    Mol Immunol; 2022 Jan; 141():287-296. PubMed ID: 34915268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
    Zahradník J; Marciano S; Shemesh M; Zoler E; Harari D; Chiaravalli J; Meyer B; Rudich Y; Li C; Marton I; Dym O; Elad N; Lewis MG; Andersen H; Gagne M; Seder RA; Douek DC; Schreiber G
    Nat Microbiol; 2021 Sep; 6(9):1188-1198. PubMed ID: 34400835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and functional identification of recombinant SARS-CoV-2 receptor binding domain (RBD) from
    Gao X; Peng S; Mei S; Liang K; Khan MSI; Vong EG; Zhan J
    Prep Biochem Biotechnol; 2022; 52(3):318-324. PubMed ID: 34187304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay.
    Tantiwiwat T; Thaiprayoon A; Siriatcharanon AK; Tachaapaikoon C; Plongthongkum N; Waraho-Zhmayev D
    Mol Biotechnol; 2023 Apr; 65(4):598-611. PubMed ID: 36103078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein.
    Shi Y; Zeida A; Edwards CE; Mallory ML; Sastre S; Machado MR; Pickles RJ; Fu L; Liu K; Yang J; Baric RS; Boucher RC; Radi R; Carroll KS
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35074895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
    Ge J; Zhang S; Zhang L; Wang X
    Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike Antigen.
    Grishin AM; Dolgova NV; Landreth S; Fisette O; Pickering IJ; George GN; Falzarano D; Cygler M
    J Mol Biol; 2022 Jan; 434(2):167357. PubMed ID: 34780781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
    Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL
    Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
    Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ
    mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
    Brown EEF; Rezaei R; Jamieson TR; Dave J; Martin NT; Singaravelu R; Crupi MJF; Boulton S; Tucker S; Duong J; Poutou J; Pelin A; Yasavoli-Sharahi H; Taha Z; Arulanandam R; Surendran A; Ghahremani M; Austin B; Matar C; Diallo JS; Bell JC; Ilkow CS; Azad T
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of spike proteins on angiotensin converting enzyme 2 (ACE2).
    Bejoy J; Williams CI; Cole HJ; Manzoor S; Davoodi P; Battaile JI; Kaushik A; Nikolaienko SI; Brelidze TI; Gychka SG; Suzuki YJ
    Arch Biochem Biophys; 2023 Oct; 748():109769. PubMed ID: 37769892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SARS-CoV-2 Spike Protein Receptor-Binding Domain Expressed in Rice Callus Features a Homogeneous Mix of Complex-Type Glycans.
    Sobrino-Mengual G; Armario-Nájera V; Balieu J; Walet-Balieu ML; Saba-Mayoral A; Pelacho AM; Capell T; Christou P; Bardor M; Lerouge P
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates.
    Kang YF; Sun C; Zhuang Z; Yuan RY; Zheng Q; Li JP; Zhou PP; Chen XC; Liu Z; Zhang X; Yu XH; Kong XW; Zhu QY; Zhong Q; Xu M; Zhong NS; Zeng YX; Feng GK; Ke C; Zhao JC; Zeng MS
    ACS Nano; 2021 Feb; 15(2):2738-2752. PubMed ID: 33464829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.